GT-02287

· Gain Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for GT-02287, covering 2025-05-06 to 2025-12-12. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy, Safety, Tolerability, and Biomarker Effects of GT-02287 in Early Parkinson's Disease [Phase 2]